30 results
8-K
EX-10.3
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
employment, nor will you engage in any other activities that conflict with the performance of your duties hereunder or present a conflict of interest
8-K
EX-10.4
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
employment, nor will you engage in any other activities that conflict with the performance of your duties hereunder or present a conflict of interest
8-K
EX-10.2
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
employment, nor will you engage in any other activities that conflict with the performance of your duties hereunder or present a conflict of interest
424B3
TRML
Tourmaline Bio Inc
15 Sep 23
Prospectus supplement
6:31am
may conclude that a financial relationship between Talaris and a principal investigator has created a conflict of interest or otherwise affected
S-4/A
exsq bdl5
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
EX-10.6
fns5kzv9z6n
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
byv9 6p9hiy
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
DEF 14A
hwob5 1xjhoub4ttyo0
29 Apr 22
Definitive proxy
4:24pm
10-K
4ddigbjloull8158ez
17 Mar 22
Annual report
4:31pm